发明名称 NEURODEGENERATIVE THERAPIES
摘要 The present invention provides a compound of formula (I) wherein: Y represents a C or N atom which may be substituted or form a cyclic group with R'" but may not be a quaternary C atom; R' is -OR1, -CONH2, -CF3, F, -OH, -NO2, -CN or -OCOR1 in which R1, is C1-3 alkyl and each may be in the beta or gamma position; R" is C1-3 alkyl or H; and R'" is H or a group consisting of 1-12 non-hydrogen atoms and may be linear, branched and/or incorporate one or more cyclic groups, cyclic groups may be aromatic and/or heterocyclic and 2 or more cyclic groups may be linked or fused and each may be substituted; or a salt, hydrate or solvate of a compound of formula (I) for use in the treatment or prevention of a neurodegenerative disorder by inhibiting formation of neurofibrillary (tau) tangles and/or by inhibiting Dyrk 1A. The invention further relates to non-therapeutic uses of these compounds.
申请公布号 WO2015118026(A1) 申请公布日期 2015.08.13
申请号 WO2015EP52330 申请日期 2015.02.04
申请人 LYTIX BIOPHARMA AS 发明人 SVENDSEN, JOHN SIGURD;STENSEN, WENCHE;LEESON, FREDERICK ALAN
分类号 A61K31/428;A61P25/28 主分类号 A61K31/428
代理机构 代理人
主权项
地址